# Axillary Reverse Mapping (ARM) in Breast Cancer Surgery to Prevent Lymphedema. (ARMtrial)

> **NCT03333226** · NA · UNKNOWN · sponsor: **University Hospital of Ferrara** · enrollment: 300 (estimated)

## Conditions studied

- Breast Cancer Lymphedema

## Interventions

- **PROCEDURE:** Axillary Reverse Mapping (ARM)

## Key facts

- **NCT ID:** NCT03333226
- **Lead sponsor:** University Hospital of Ferrara
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-17
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03333226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03333226, "Axillary Reverse Mapping (ARM) in Breast Cancer Surgery to Prevent Lymphedema. (ARMtrial)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03333226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*